ESC Premium Access

Apolipoprotein C-III Reduction in Cardiovascular Disease

Presentation

About the speaker

Doctor Jean-Claude Tardif

Montreal Heart Institute, Montreal (Canada)
5 presentations
0 follower

2 more presentations in this session

ANGPTL3 antisense oligonucleotide to lower triglycerides

Speaker: Doctor D. Gaudet (Montreal, CA)

Thumbnail

Final Results of the EVAPORATE Trial

Speaker: Doctor M. Budoff (Torrance, US)

Thumbnail

Access the full session

Late-Breaking Science in Lipids

Speakers: Doctor J. Tardif, Doctor D. Gaudet, Doctor M. Budoff
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

ESC Premium Access

Will coronary atherosclerosis be eliminated?

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk